HomeProductsBioactive CompoundsJAK/STAT SignalingEGFRTucatinib
Chemical structure of CAS 937263-43-9

Tucatinib

CAS No.937263-43-9
MDL No.MFCD22380467
MFC26H24N8O2
MW480.50
InChI KeySDEAXTCZPQIFQM-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.937263-43-9
Product NameTucatinib

Biological Targets

ERBB2

Associated Conditions

metastasis·chronic myelogenous leukemia·liver disease·lung cancer·colon carcinoma·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases.

Chemico-biological interactions • Vol. 381 • 2023
PMID: 37263554DOI: 10.1016/j.cbi.2023.110574

Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models.

Molecular cancer therapeutics • Vol. 19, Issue 4 • 2020
PMID: 32241871DOI: 10.1158/1535-7163.MCT-19-0873

Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2-Advanced Solid Tumors, with an Expansion Cohort in HER2 Metastatic Breast Cancer (MBC).

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 23, Issue 14 • 2017
PMID: 28053022DOI: 10.1158/1078-0432.CCR-16-1496

[Use of luminescence for determining oxytetracycline hydrochloride in drug preparations].

Farmatsiia • Vol. 25, Issue 2 • 1976
PMID: 5319

Documentation

Similar Products